NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
Mary Kiige/LinkedIn
Sep 7, 2025, 14:16

Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge

Mary Kiige, Founder of Kikwetu Digital Solutions and Digital Innovation Strategist, has shared a post on LinkedIn:

“Can BHOC – Biological Hemoglobin Oxygen Carrier Replace Blood?
The short answer: No!

But here’s why that matters, and why it’s still revolutionary.
What BHOC cannot do:
It doesn’t replace platelets or plasma proteins.
It can’t provide clotting factors or immune cells.
It’s not a complete substitute for blood transfusion.

What BHOC can do:
Deliver oxygen instantly to tissues when red cells can’t.
Work for all blood types (no cross-matching needed).
Stay shelf-stable for 3+ years at room temperature.
Serve as a bridge therapy, buying time until blood or definitive treatment is available.

Real-world use:
Approved in South Africa since 2001.
Used under FDA Expanded Access in the U.S. for patients when blood was not an option.
Applied successfully in trauma, surgery, transplantation, and rare antibody cases.

The takeaway:
BHOC isn’t a blood replacement, it’s a lifesaving oxygen bridge.
When blood is scarce or unavailable, it creates the one thing medicine needs most: TIME!”

Stay updated with Hemostasis Today.

BHOC Biological Hemoglobin Oxygen Carrier Blood Blood Transfusion clotting factors Cross-matching FDA Health Hematology Hemostasis Hemostasis Today Mary Kiige Oxygen 𝗣𝗹𝗮𝘀𝗺𝗮 platelets Rare Antibody thrombosis Transfusion Medicine Transplantation
NewsFeed